Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 4Recurrence 3Solid Tumor Malignancy 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdoid Tumor 1Recurrent Squamous Cell Lung Carcinoma 1Neurofibrosarcoma 1Neoplasm, Residual 1Lymphoma, Large B-Cell, Diffuse 1Liposarcoma 1Immunoglobulin Light-chain Amyloidosis 1Central Nervous System Neoplasms 1Amyloidosis 1Alzheimer Disease 1

Interventions

selinexor 1XENP 1595 1Tablets 1Electroencephalography 1Donepezil 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Alzheimer Disease × selinexor × Clear all
NCT04984330 2022-11-17

STARR

Weill Medical College of Cornell University

Phase EARLY_PHASE1 Withdrawn
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡